John DiBella serves as the Business Unit President of PBPK and CHEM Solutions at Simulations Plus, Inc., a leading provider of modeling and simulation software for the pharmaceutical, biotechnology, chemicals, and consumer goods industries. In his role, DiBella is responsible for overseeing the strategic direction and growth of the company's physiologically based pharmacokinetic (PBPK) and cheminformatics solutions, which are critical tools used by researchers and scientists to predict the behavior of drugs and chemicals within biological systems. With an extensive background in the life sciences and technology sectors, DiBella brings a wealth of experience and expertise to his position at Simulations Plus. Prior to joining the company, he held various leadership roles at renowned organizations, where he successfully drove the development and commercialization of innovative software solutions. DiBella's deep understanding of the industry, coupled with his strong business acumen, has been instrumental in expanding Simulations Plus' PBPK and cheminformatics offerings, enabling the company to better serve its clients and maintain its position as a market leader. Under DiBella's leadership, the PBPK and CHEM Solutions business unit has experienced significant growth and success. He has spearheaded the development of cutting-edge software tools and services that have empowered researchers to make more informed decisions, accelerate drug discovery and development processes, and ultimately improve patient outcomes. DiBella's commitment to fostering a culture of innovation and collaboration within the company has been a key driver of Simulations Plus' continued success in the highly competitive life sciences market.